Hall Laurie J Trustee maintained its position in Zimmer Biomet Holdings Inc (NYSE:ZBH) during the first quarter, Holdings Channel reports. The firm owned 2,249 shares of the company’s stock at the end of the first quarter. Hall Laurie J Trustee’s holdings in Zimmer Biomet Holdings were worth $270,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Huntington National Bank boosted its position in Zimmer Biomet Holdings by 23.4% in the third quarter. Huntington National Bank now owns 10,033 shares of the company’s stock worth $1,305,000 after buying an additional 1,905 shares in the last quarter. Stack Financial Management Inc boosted its position in shares of Zimmer Biomet Holdings by 0.5% in the third quarter. Stack Financial Management Inc now owns 67,419 shares of the company’s stock worth $8,766,000 after buying an additional 340 shares during the period. United Services Automobile Association boosted its position in shares of Zimmer Biomet Holdings by 1.8% in the third quarter. United Services Automobile Association now owns 356,415 shares of the company’s stock worth $46,341,000 after buying an additional 6,465 shares during the period. Advantus Capital Management Inc boosted its position in shares of Zimmer Biomet Holdings by 2.2% in the third quarter. Advantus Capital Management Inc now owns 19,809 shares of the company’s stock worth $2,576,000 after buying an additional 430 shares during the period. Finally, Mitsubishi UFJ Trust & Banking Corp boosted its position in shares of Zimmer Biomet Holdings by 1.3% in the third quarter. Mitsubishi UFJ Trust & Banking Corp now owns 409,082 shares of the company’s stock worth $53,189,000 after buying an additional 5,253 shares during the period. 86.62% of the stock is currently owned by institutional investors and hedge funds.
Shares of Zimmer Biomet Holdings Inc (NYSE:ZBH) traded up 0.73% during mid-day trading on Thursday, reaching $120.04. 423,195 shares of the company’s stock traded hands. Zimmer Biomet Holdings Inc has a 12-month low of $95.63 and a 12-month high of $133.21. The firm has a market capitalization of $24.14 billion, a price-to-earnings ratio of 79.50 and a beta of 1.20. The stock has a 50-day moving average price of $119.51 and a 200 day moving average price of $114.46.
Zimmer Biomet Holdings (NYSE:ZBH) last posted its earnings results on Tuesday, January 31st. The company reported $2.14 earnings per share for the quarter, topping analysts’ consensus estimates of $2.11 by $0.03. Zimmer Biomet Holdings had a net margin of 3.90% and a return on equity of 16.66%. The firm had revenue of $2.01 billion for the quarter, compared to the consensus estimate of $1.98 billion. During the same period in the previous year, the firm posted $2.09 EPS. The business’s quarterly revenue was up 4.1% on a year-over-year basis. Analysts anticipate that Zimmer Biomet Holdings Inc will post $8.59 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, April 28th. Stockholders of record on Friday, March 31st will be issued a $0.24 dividend. The ex-dividend date of this dividend is Wednesday, March 29th. This represents a $0.96 dividend on an annualized basis and a dividend yield of 0.81%. Zimmer Biomet Holdings’s dividend payout ratio (DPR) is presently 65.31%.
WARNING: “Hall Laurie J Trustee Has $270,000 Stake in Zimmer Biomet Holdings Inc (ZBH)” was originally reported by sleekmoney and is the property of of sleekmoney. If you are reading this news story on another domain, it was illegally stolen and republished in violation of United States & international copyright and trademark legislation. The original version of this news story can be viewed at http://sleekmoney.com/hall-laurie-j-trustee-has-270000-stake-in-zimmer-biomet-holdings-inc-zbh/1739251.html.
A number of research analysts have recently issued reports on the company. Zacks Investment Research cut Zimmer Biomet Holdings from a “hold” rating to a “sell” rating in a research note on Thursday. Robert W. Baird reaffirmed an “outperform” rating and set a $136.00 price objective (up from $130.00) on shares of Zimmer Biomet Holdings in a research note on Wednesday, February 1st. Canaccord Genuity set a $144.00 price objective on Zimmer Biomet Holdings and gave the company a “buy” rating in a research note on Tuesday, January 31st. Oppenheimer Holdings Inc. set a $132.00 price objective on Zimmer Biomet Holdings and gave the company a “buy” rating in a research note on Wednesday, February 1st. Finally, Royal Bank of Canada reaffirmed a “buy” rating and set a $133.00 price objective on shares of Zimmer Biomet Holdings in a research note on Tuesday, March 14th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the stock. Zimmer Biomet Holdings currently has a consensus rating of “Buy” and an average target price of $136.31.
In other news, insider David C. Dvorak sold 1,040 shares of the business’s stock in a transaction dated Monday, March 20th. The shares were sold at an average price of $121.63, for a total value of $126,495.20. Following the sale, the insider now directly owns 294,077 shares in the company, valued at approximately $35,768,585.51. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 1.22% of the company’s stock.
Zimmer Biomet Holdings Company Profile
Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.
Want to see what other hedge funds are holding ZBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zimmer Biomet Holdings Inc (NYSE:ZBH).
This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/hall-laurie-j-trustee-has-270000-stake-in-zimmer-biomet-holdings-inc-zbh/1739251.html
Receive News & Ratings for Zimmer Biomet Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.